Main Article Content
BACKGROUND Coastal life may offer chances for physical exercise, such as swimming or strolling on the beach, which can be helpful for treating PCOS. 15% to 20% of women of reproductive age are affected by the common metabolic and endocrine disorder known as polycystic ovarian syndrome (PCOS).It is linked to an increase in the occurrence of a number of clinical issues, such as infertility, insulin resistance, menstrual irregularities, and obesity. For women with PCOS, The most common methods remain dietary adjustments and weight loss.. Any form of special education may benefit this category of patients as intense physiotherapy.
AIM: The present investigation sought to determine how high-intensity interval training affected body mass index, plasma glucose and insulin levels in people with polycystic ovarian syndrome..
METHODOLOGY: The population comprised of 30 individuals who were aged between 18 to 40 and diagnosed with PCOS were included and divided into two groups i.e., group A -(experimental group) (n=15) and group B - (control group) (n=15). Group A participants performed high intensity interval training along with medications while group B participants followed the medications alone. Intervention was done for 40 minutes every day, 4 days per week for the duration of 6 weeks. Body mass index, plasma venous glucose and insulin were measured before and after the intervention period.
RESULTS: Group A (experimental group) has shown significant reduction in body mass index, plasma glucose and insulin compared to the baseline (p < 0.05). However, group B (the control group) did not experience any significant changes in body mass index, plasma glucose, or insulin.) (p > 0.05).
CONCLUSION: In polycystic ovarian syndrome patients, high-intensity interval exercise improved metabolic health and body weight.
Rosenberg, S. L. (2019). The Relationship Between PCOS and Obesity: Which Comes First? The Science Journal of the Lander College of Arts and Sciences, 13(1).
Veena et al (2019). effect of Aerobic exercise and life style intervention among young women With Polycystic Ovary Syndrome. Research J. Pharm. And Tech 2019; 12(9):4269-4273.
Rui Wang et al (2014) The Rotterdam criteria for polycystic ovary syndrome: evidence - based criteria? https://doi.org/10.1093/humrep/dew287.
Erin K. Barthelmess et al (2014) Polycystic ovary syndrome: current status and future perspective PMID: 24389146.
Rasgon Nl et al, (2003) Depression in women with polycystic ovary syndrome: Clinical and biochemical correlates. J Affective Dis.;74(3):299-304.
Dunaif A. Insulin action in the polycystic ovary syndrome. Endocrinology and metabolism clinics of North America. 1999; 28(2):341–59. PMID: 10352922.
Kim JJ, Choi YM. Dyslipidemia in women with polycystic ovary syndrome. Obstetrics & gynecology science. 2013; 56(3):137–42. Epub 2013/12/12. Doi: 10.5468/ogs.2013.56.3.137 PMID: 24327994; PubMed Central PMCID: PMCPmc3784112.
Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Molecular and cellular endocrinology. 2011; 335(1):30–41. Doi: 10.1016/j.mce.2010.08.002 PMID: 20708064.
Moron LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011:CD007500.
Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod. 2001; 16(6):1255–60. PMID: 11387301.
Alvarez-Blasco F, Botella-Carretero JI, San Millan JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006; 166(19):2081–6. Doi: 10.1001/archinte.166.19.2081 PMID: 17060537.
R.L. Thomson, et al (2009) Comparison of Aerobic Exercise capacity and muscle Strength in overweight women with and without PCOS: A Review of Literature. BJOG 2009,.116. 1242-1250.
YarkinOzenli, Bulent, et al (2008) Anxiety, depression and ways of coping skills by Women with PCOS: A Cross Sectional Study. Turkish-German GynecolAsso, vol.9 (4): 190-194.
Booth, F. W., Gordon, S. E., Carlson, C. J., and Hamilton, M. T. (2000). Waging War on modern chronic diseases: primary prevention through exercise biology. J. Appl. Physiol. 88, 774–787. Doi: 10.1152/jappl.2000.88.2.774.
Roberts, C. K., and Barnard, R. J. (2005). Effects of exercise and diet on chronic disease. J. Appl. Physiol. 98, 3–30. Doi: 10.1152/japplphysiol.00852.2004.
Stepto, N. K., Patten, R. K., Tassone, E. C., Misso, M. L., Brennan, L., Boyle, J., et al. (2019). Exercise recommendations for women with polycystic ovary syndrome: is the evidence enough? Sports Med. 49, 1143–1157. Doi: 10.1007/s40279-019-01133-6.
Teede, H. J., Misso, M. L., Costello, M. F., Dokras, A., Laven, J., Moran, L., et al. (2018a). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Ster.110, 364–379. Doi: 10.1016/j.fertnstert.2018.05.004.
Alahmadi MA (2014) High-intensity Interval Training and Obesity. J Nov Physiother 4: 211. Doi:10.4172/2165-7025.1000211.
De Feo P. Is high-intensity exercise better than moderate-intensity Exercise for weight loss? Nutr. Metab. Cardiovas. Dis. 2013; 23:1037–1042.
Patten RK, Boyle RA, Moholdt T, Kiel I,Hopkins WG, Harrison CL and Stepto NK (2020) Exercise Interventions in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front. Physiol. 11: 606.doi: 10.3389/fphys.2020.00606.
Boutcher SH (2011) High-intensity intermittent exercise and fat loss. J Obes 2011: 868305.
Gibala, M.J., et al., 2012. Physiological adaptations to low-volume, high intensity interval training in health and disease. The journal of physiology,59, 1077–1084.
Polycystic Ovary Syndrome edited by Srabani Mukherjee published by InTech Janeza Trdine 9, 51000 Rijeka, Croatia ISBN 978-953-51-0094-2.
H. Ş. Aktaş, Y. E. Uzun, O. Kutlu, H. H. Pençe, F. Özçelik, E. Ö. Çil, L. Irak, Ö.Altun, M. Özcan, N. Özsoy, Ş. Aydın Yoldemir, S. Kalyon, Y. Arman & T. Tükek (2019): The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome, Archives of Physiology and Biochemistry, DOI: 10.1080/13813455.2019.1662450.
Fealy, C.E., et al., 2018. Functional high-intensity exercise training ameliorates insulin resistance and cardiometabolic risk factors in type 2 diabetes. Experimental physiology, 103(7), 985–994.
Hamasaki, H., 2018. Interval exercise therapy for type 2 diabetes. Current Diabetes reviews, 14(2), 129–137.
Dominic, D., Kishore, S. (2021). Effect of Modified High Intensity Interval Training on Fat Loss. Central European Journal of Sport Sciences and Medicine, 3 (35), 49–56. DOI: 10.18276/cej.2021.3-05.
Mubarra Rao, et al. HIIT for the intervention of PCOS Obstet Gynecol Sci 2022;65(4):368-375 https://doi.org/10.5468/ogs.22002,eISSN 2287-8580.
Perry CG, Heigenhauser GJ, Bonen A, Spriet LL. High-intensity aerobic Interval training increases fat and carbohydrate metabolic capacities in Human skeletal muscle. Appl Physiol Nutr Metab 2008; 33:1112–23.
Burgomaster KA, Heigenhauser GJ, Gibala MJ. Effect of short-term sprint inTerval training on human skeletal muscle carbohydrate metabolism during Exercise and time-trial performance. J Appl Physiol (1985) 2006; 100:2041–7.
Gibala MJ, Little JP, van Essen M, Wilkin GP, Burgomaster KA, Safdar A, et al. Short-term sprint interval versus traditional endurance training: similar initial Adaptations in human skeletal muscle and exercise performance. J Physiol 2006; 575:901–11.
Varghese A, Balu P, R S, Muthu J, Vineela K. Salivary Interleukin-6 Levels among Polycystic Ovary Syndrome Patients with and Without Chronic Periodontitis - A Comparative Study. Contemp Clin Dent. 2019 Jul-Sep;10(3):498-501. doi: 10.4103/ccd.ccd_848_18.
Santhiya R, Habeebullah S, Ghose S. Correlation of phenotypes of polycystic ovarian syndrome with anti-Müllerian hormone levels. Sahel Med J 2021;24:15-21.
Seetesh Ghose, MD, Karri Lakshmi Manasa and Mangaiyarkarasi Ravirajan , Serum Vitamin D Levels in Different Phenotypes of Polycystic Ovarian.(2022).Int. J. Life Sci. Pharma Res.12(6), L18-22 http://dx.doi.org/10.22376/ijpbs/lpr.2022.12.6.SP25.LL18-22